Total Payments
$908,883
2024 Payments
$149,555
Companies
45
Transactions
1,095
Medicare Patients
5,958
Medicare Billing
$1.3M
Payment Breakdown by Category
Consulting$472,308 (52.0%)
Other$371,224 (40.8%)
Travel$35,158 (3.9%)
Food & Beverage$30,033 (3.3%)
Education$123.92 (0.0%)
Gifts$36.64 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $472,308 | 248 | 52.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $223,924 | 103 | 24.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $69,975 | 27 | 7.7% |
| Honoraria | $44,050 | 20 | 4.8% |
| Travel and Lodging | $35,158 | 93 | 3.9% |
| Food and Beverage | $30,033 | 582 | 3.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $25,800 | 17 | 2.8% |
| Long term medical supply or device loan | $7,475 | 1 | 0.8% |
| Education | $123.92 | 2 | 0.0% |
| Gift | $36.64 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $177,787 | 145 | $0 (2024) |
| Alcon Laboratories Inc | $143,910 | 156 | $0 (2018) |
| Allergan, Inc. | $90,821 | 101 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $77,838 | 75 | $0 (2024) |
| Dompe US, Inc. | $70,173 | 65 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $55,076 | 85 | $0 (2024) |
| Carl Zeiss Meditec, Inc. | $50,975 | 46 | $0 (2024) |
| Sight Sciences, Inc. | $39,527 | 49 | $0 (2024) |
| Alcon Research LLC | $33,101 | 12 | $0 (2024) |
| Shire North American Group Inc | $19,919 | 30 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149,555 | 140 | Bausch & Lomb Americas Inc. ($37,431) |
| 2023 | $126,031 | 146 | Sun Pharmaceutical Industries Inc. ($32,380) |
| 2022 | $115,527 | 138 | Alcon Vision LLC ($36,701) |
| 2021 | $98,246 | 119 | Alcon Vision LLC ($46,602) |
| 2020 | $95,992 | 78 | Alcon Vision LLC ($16,511) |
| 2019 | $94,313 | 170 | Alcon Vision LLC ($27,729) |
| 2018 | $112,957 | 133 | Alcon Laboratories Inc ($85,246) |
| 2017 | $116,263 | 171 | Alcon Laboratories Inc ($58,664) |
All Payment Transactions
1,095 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Glaukos Corporation | — | Long term medical supply or device loan | Cash or cash equivalent | $7,474.85 | General |
| 12/30/2024 | Nordic Pharma, Inc. | Lacrifill (Device) | Consulting Fee | Cash or cash equivalent | $10,216.06 | General |
| Category: Opthalamics | ||||||
| 12/19/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: Corneal Health | ||||||
| 12/12/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $124.82 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Sight Sciences, Inc. | TEARCARE SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: Ophthalmology | ||||||
| 12/01/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: Ophthalmology | ||||||
| 11/27/2024 | Sight Sciences, Inc. | TEARCARE SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: Ophthalmology | ||||||
| 11/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: Ophthalmology | ||||||
| 11/27/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/21/2024 | Alcon Research LLC | Clareon (Device), AcrySof IQ PanOptix UV IOL, AcrySof IQ VIVITY | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Sight Sciences, Inc. | TEARCARE SYSTEM (Device) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: Ophthalmology | ||||||
| 11/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $119.26 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Dompe US, Inc. | OXERVATE (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,900.00 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/07/2024 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/07/2024 | Dompe US, Inc. | OXERVATE (Drug) | Travel and Lodging | Cash or cash equivalent | $28.00 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/06/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: Corneal Health | ||||||
| 11/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $101.30 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/04/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/29/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Dompe US, Inc. | OXERVATE (Drug) | Travel and Lodging | In-kind items and services | $688.30 | General |
| Category: SOLUTION/ DROPS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,541 | 1,760 | $1.3M | $333,925 |
| 2022 | 17 | 1,416 | 1,650 | $1.0M | $273,190 |
| 2021 | 21 | 1,637 | 1,929 | $1.5M | $376,472 |
| 2020 | 20 | 1,364 | 1,656 | $1.1M | $275,594 |
Total Patients
5,958
Total Services
6,995
Medicare Billing
$1.3M
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 129 | 169 | $292,370 | $68,884 | 23.6% |
| 65756 | Transplantation of outer layer of corneal tissue | Facility | 2023 | 65 | 71 | $265,540 | $67,983 | 25.6% |
| 66986 | Exchange of prosthetic lens | Facility | 2023 | 53 | 58 | $166,750 | $41,195 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 367 | 493 | $95,760 | $33,777 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 243 | 243 | $87,480 | $31,884 | 36.4% |
| 65755 | Penetrating transplantation of tissue from 1 cornea to other cornea (in pseudophakia) | Facility | 2023 | 20 | 20 | $80,300 | $21,109 | 26.3% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 19 | 23 | $54,510 | $13,822 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 131 | $35,625 | $13,326 | 37.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 34 | 37 | $39,960 | $10,413 | 26.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 108 | 118 | $21,960 | $7,423 | 33.8% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 16 | 16 | $45,600 | $7,071 | 15.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 148 | 161 | $17,710 | $5,686 | 32.1% |
| 67010 | Partial removal of eye fluid between lens and retina with mechanical removal of eye fluid | Facility | 2023 | 14 | 14 | $24,220 | $3,223 | 13.3% |
| 92025 | Ct scan of cornea | Office | 2023 | 91 | 95 | $7,570 | $2,695 | 35.6% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 46 | 46 | $3,910 | $1,525 | 39.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 15 | 15 | $4,055 | $1,474 | 36.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 16 | 16 | $5,120 | $1,391 | 27.2% |
| 92134 | Imaging of retina | Office | 2023 | 17 | 17 | $1,515 | $551.71 | 36.4% |
| 92071 | Fitting of contact lens for treatment of eye surface disease | Office | 2023 | 13 | 17 | $1,300 | $491.06 | 37.8% |
| 65756 | Transplantation of outer layer of corneal tissue | Facility | 2022 | 64 | 69 | $258,060 | $66,146 | 25.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 109 | 159 | $275,070 | $63,803 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 284 | 379 | $73,575 | $26,003 | 35.3% |
| 66986 | Exchange of prosthetic lens | Facility | 2022 | 31 | 35 | $100,625 | $23,301 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 169 | 169 | $60,800 | $21,046 | 34.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 251 | 311 | $58,680 | $19,786 | 33.7% |
About Dr. Brandon Ayres, MD
Dr. Brandon Ayres, MD is a Ophthalmology healthcare provider based in Bala Cynwyd, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710985460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brandon Ayres, MD has received a total of $908,883 in payments from pharmaceutical and medical device companies, with $149,555 received in 2024. These payments were reported across 1,095 transactions from 45 companies. The most common payment nature is "Consulting Fee" ($472,308).
As a Medicare-enrolled provider, Ayres has provided services to 5,958 Medicare beneficiaries, totaling 6,995 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Bala Cynwyd, PA
- Active Since 07/07/2005
- Last Updated 11/03/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1710985460
Products in Payments
- AcrySof (Device) $79,057
- Cequa (Drug) $51,787
- Centurion (Device) $43,368
- OXERVATE (Drug) $40,944
- XIIDRA (Drug) $38,384
- MIEBO (Drug) $37,622
- ORA (Device) $33,776
- AcrySof IQ VIVITY (Device) $31,965
- AcrySof IQ VIVITY IOL (Device) $31,525
- ACTIVEFOCUS (Device) $31,426
- Oxervate (Drug) $26,904
- VUITY (Drug) $26,584
- RESTASIS (Drug) $26,259
- Clareon (Device) $20,958
- TEARCARE SYSTEM (Device) $18,868
- AcrySof IQ PanOptix (Device) $14,636
- ReSTOR (Device) $14,171
- LOTEMAX SM (Drug) $14,124
- ARTEVO 800 (Device) $12,355
- XDEMVY (Drug) $12,256
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Bala Cynwyd
Dr. Richard Tipperman, M.d, M.D
Ophthalmology — Payments: $144,564
Ophthalmology $144,564
Dr. Michael Pro, Md, MD
Ophthalmology — Payments: $21,153
Ophthalmology $21,153
Elizabeth Dale, Md, MD
Ophthalmology — Payments: $16,146
Ophthalmology $16,146
Dr. Brenton Finklea, M.d, M.D
Ophthalmology — Payments: $16,006
Ophthalmology $16,006
Ralph Di Giovanni, M.d, M.D
Ophthalmology — Payments: $7,295
Ophthalmology $7,295
Dr. Katie Schrack, M.d, M.D
Ophthalmology — Payments: $6,311
Ophthalmology $6,311